SEOUL, Aug. 4 (Korea Bizwire) — Hanmi Pharmaceutical said Tuesday that it has exported technology for a liver treatment drug material to leading global drugmaker Merck Sharp & Dohme (MSD). The deal is for the efinopegdutide (HM12525A) candidate material that has potential to be used on people with nonalcoholic steatohepatitis (NASH) conditions, a kind of [...]
SEOUL, Oct. 31 (Korea Bizwire) – Domestic pharmaceutical firms have started to release sensitive information that may play to their disadvantage, mainly in order to eliminate any misunderstanding or speculation by not disclosing information in advance. The move is also driven by the recent Hanmi Pharmaceutical controversy, in which the company allegedly leaked insider information [...]
SEOUL, Oct. 4 (Korea Bizwire) – South Korea’s health authorities said Tuesday that they have decided to “conditionally” maintain sales approval for a controversial lung cancer treatment developed by the country’s leading drugmaker Hanmi Pharmaceutical Co. amid side effect concerns. The Ministry of Food and Drug Safety (MFDS) said it will maintain an earlier decision [...]
SUZHOU, China, May 23 (Korea Bizwire) — Suzhou Industrial Park played host to world-leading pharmaceutical companies and venture capitalists at the ChinaBio Partnering Forum 2016 on May 18, helping to optimize the innovation and capital chains of the life-sciences ecosystem in the region. It is the fourth time the forum – which is the biggest [...]
SEOUL, Nov. 24 (Korea Bizwire) – Hanmi Pharmaceutical Co. is heading toward its best year ever with six licensing deals and collaboration projects worth a combined 7.6 trillion won (US$6.55 billion). The South Korean company has bagged a series of deals on licensing of its pipeline products and collaborative research and development of early treatment [...]
SEOUL, March 26 (Korea Bizwire) — The market value of bio and health care shares listed on the South Korean stock markets surpassed 30 trillion won (US$27.22 billion) for the first time as investors pinned high hopes on their future growth, the bourse main operator Korea Exchange (KRX) said Thursday. The combined market cap of the [...]
SEOUL, Nov. 12 (Korea Bizwire) – Something expedient but controversial, rising cases of wealth transfer taking advantage of lowered stock prices amid the stagnant economy among some owners of the domestic conglomerates, have come to the fore of late. According to Chaebul.com, as of November 6, minors who own stocks valued over 100 million won [...]